vs
Side-by-side financial comparison of LendingClub Corp (LC) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
LendingClub Corp is the larger business by last-quarter revenue ($252.3M vs $158.6M, roughly 1.6× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 20.5%, a 50.7% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 15.9%).
LendingClub Corporation is an American financial services company headquartered in San Francisco, California. It was the first peer-to-peer lender to register its offerings as securities with the Securities and Exchange Commission (SEC), and to offer loan trading on a secondary market. At its height, LendingClub was the world's largest peer-to-peer lending platform. The company reported that $15.98 billion in loans had been originated through its platform up to December 31, 2015.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
LC vs STOK — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $252.3M | $158.6M |
| Net Profit | $51.6M | $112.9M |
| Gross Margin | — | — |
| Operating Margin | — | 70.2% |
| Net Margin | 20.5% | 71.2% |
| Revenue YoY | 15.9% | 3661.1% |
| Net Profit YoY | 341.0% | 528.0% |
| EPS (diluted) | $0.44 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $252.3M | — | ||
| Q4 25 | $266.5M | — | ||
| Q3 25 | $266.2M | — | ||
| Q2 25 | $248.4M | — | ||
| Q1 25 | $217.7M | $158.6M | ||
| Q4 24 | $217.2M | $22.6M | ||
| Q3 24 | $201.9M | — | ||
| Q2 24 | $187.2M | — |
| Q1 26 | $51.6M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $44.3M | — | ||
| Q2 25 | $38.2M | — | ||
| Q1 25 | $11.7M | $112.9M | ||
| Q4 24 | — | $-10.5M | ||
| Q3 24 | $14.5M | — | ||
| Q2 24 | $14.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | 18.8% | — | ||
| Q3 25 | 21.5% | — | ||
| Q2 25 | 21.7% | — | ||
| Q1 25 | 7.2% | 70.2% | ||
| Q4 24 | 5.1% | -60.4% | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 10.4% | — |
| Q1 26 | 20.5% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 16.6% | — | ||
| Q2 25 | 15.4% | — | ||
| Q1 25 | 5.4% | 71.2% | ||
| Q4 24 | — | -46.4% | ||
| Q3 24 | 7.2% | — | ||
| Q2 24 | 8.0% | — |
| Q1 26 | $0.44 | — | ||
| Q4 25 | $0.36 | — | ||
| Q3 25 | $0.37 | — | ||
| Q2 25 | $0.33 | — | ||
| Q1 25 | $0.10 | $1.90 | ||
| Q4 24 | $0.08 | $-0.15 | ||
| Q3 24 | $0.13 | — | ||
| Q2 24 | $0.13 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.5B | $350.1M |
| Total Assets | $11.9B | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $274.8M | ||
| Q4 24 | — | $128.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $0 | — | ||
| Q3 25 | $0 | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | $0 | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.4B | $350.1M | ||
| Q4 24 | $1.3B | $229.0M | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — |
| Q1 26 | $11.9B | — | ||
| Q4 25 | $11.6B | — | ||
| Q3 25 | $11.1B | — | ||
| Q2 25 | $10.8B | — | ||
| Q1 25 | $10.5B | $406.9M | ||
| Q4 24 | $10.6B | $271.6M | ||
| Q3 24 | $11.0B | — | ||
| Q2 24 | $9.6B | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $131.8M |
| Free Cash FlowOCF − Capex | — | $131.7M |
| FCF MarginFCF / Revenue | — | 83.0% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-2.7B | — | ||
| Q3 25 | $-770.8M | — | ||
| Q2 25 | $-713.1M | — | ||
| Q1 25 | $-339.3M | $131.8M | ||
| Q4 24 | $-2.6B | $-23.2M | ||
| Q3 24 | $-669.8M | — | ||
| Q2 24 | $-932.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | $-2.9B | — | ||
| Q3 25 | $-791.8M | — | ||
| Q2 25 | $-803.8M | — | ||
| Q1 25 | $-352.3M | $131.7M | ||
| Q4 24 | $-2.7B | $-23.2M | ||
| Q3 24 | $-682.3M | — | ||
| Q2 24 | $-945.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | -1076.0% | — | ||
| Q3 25 | -297.4% | — | ||
| Q2 25 | -323.5% | — | ||
| Q1 25 | -161.8% | 83.0% | ||
| Q4 24 | -1237.8% | -102.7% | ||
| Q3 24 | -338.0% | — | ||
| Q2 24 | -504.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | 52.7% | — | ||
| Q3 25 | 7.9% | — | ||
| Q2 25 | 36.5% | — | ||
| Q1 25 | 6.0% | 0.1% | ||
| Q4 24 | 25.0% | 0.2% | ||
| Q3 24 | 6.2% | — | ||
| Q2 24 | 6.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -17.41× | — | ||
| Q2 25 | -18.68× | — | ||
| Q1 25 | -29.07× | 1.17× | ||
| Q4 24 | — | — | ||
| Q3 24 | -46.33× | — | ||
| Q2 24 | -62.57× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
